Orthorexia Nervosa in Fibromyalgia

NCT06947200 | Recruiting

• 1 other identifier: BeylikduzuStateH18
• Study Type: observational
• Target: 84
• Locations: 1 country
• Sites: 1

Brief Summary

This clinical cross-sectional study will include 84 female patients aged between 18 and 65 years who have been diagnosed with fibromyalgia syndrome according to the 2010 American College of Rheumatology diagnostic criteria. Sociodemographic data will be recorded at the beginning of the study. Pain severity will be assessed using the Visual Analog Scale (VAS). Orthorexia nervosa-related symptoms will be evaluated with the ORTO-11 scale. Body image will be assessed with the Body Appreciation Scale 2, mood will be evaluated using the Hospital Anxiety and Depression Scale (HADS), and fibromyalgia-related impact will be assessed with the Fibromyalgia Impact Questionnaire (FIQ).

Conditions

Fibromyalgia

Outcome Measures

Primary Outcomes (1)

• ORTO-11 Scale

  The ORTO-11 assesses orthorexic tendencies, which refer to an unhealthy obsession with healthy eating. It consists of 11 items rated on a 4-point Likert scale. Total scores range from 11 to 44, with lower scores indicating a higher risk of orthorexia nervosa.

  Baseline

Secondary Outcomes (4)

• Hospital Anxiety Scale (HADS-A):

  Baseline

• Hospital Depression Scale (HADS-D):

  Baseline

• Body Appreciation Scale-2 (BAS-2)

  Baseline

• Fibromyalgia Impact Questionnaire (FIQ)

  Baseline

Study Arms (1)

fibromyalgia group

Other: Fibromyalgia

Interventions

Fibromyalgia OTHER

no intervention

Also known as: No intervention

fibromyalgia group

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: female
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients with fibromyalgia syndrome

You may qualify if:

• Female patients aged 18-65 years.
• Diagnosis of fibromyalgia syndrome according to the 2010 American College of Rheumatology diagnostic criteria.
• Willingness to participate and provision of written informed consent.

You may not qualify if:

• Refusal to participate.
• Presence of diagnosed psychiatric disorders.
• Presence of cognitive impairment.
• Use of medications that may affect mood.

Sponsors & Collaborators

• Beylikduzu State Hospital: lead

Study Sites (1)

Beylikdüzü State Hospital

Istanbul, 34147, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Neuromuscular Diseases; Nervous System Diseases

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principle Investigator

Study Record Dates

• First Submitted: April 20, 2025
• First Posted: April 27, 2025
• Study Start: April 20, 2025
• Primary Completion: May 20, 2025
• Study Completion: May 20, 2025
• Last Updated: April 27, 2025

Record last verified: 2025-04

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)